/
/
New Jersey: Hackensack Meridian Health's New Myeloma Institute
New Jersey: Hackensack Meridian Health's New Myeloma Institute image
New Jersey: Hackensack Meridian Health's New Myeloma Institute
Posted Oct 14, 2018

The team at Hackensack Meridian Health, part of New Jersey’s largest and most comprehensive healthcare network, recently announced the opening of the Institute for Multiple Myeloma. The Institute will be located in a state-of-the art research facility at the Hackensack Meridian Health Interprofessional Health Sciences Campus in Nutley and Clifton, NJ, and led by founding director, David Siegel, M.D., Ph. D. Dr. Siegel is also chief of the Multiple Myeloma Division at John Theurer Cancer Center at Hackensack University Medical Center.

Under the leadership of Dr. Siegel, and alongside hematology experts like André Goy, MD, MS, chairman and executive director, division chief of Lymphoma, John Theurer Cancer Center, the Institute will focus on driving innovative research, and continuing the development of precision medicine for each patient. The John Theurer Cancer Center currently is running studies including CAR T-cells, NK-cell based therapies, and Bone Marrow Transplantation.

The John Theurer Cancer Center at Hackensack University Medical Center has built one of the world’s largest multiple myeloma programs, with more than 2,000 patients on active therapy… John Theurer Cancer Center and Georgetown Lombardi Comprehensive Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, established a research partnership. This strategic collaboration has allowed the two institutions to leverage resources, capabilities, and expertise to accelerate discoveries in cancer research and clinical care. The combined strength also sparks collaborations with other academic cancer centers as well as the pharmaceutical industry. The shared goal of the research collaboration fosters combined leadership in basic cancer research and clinical care for the betterment of their patients. (Hackensack Meridian Health, 2018)

The Institute for Multiple Myeloma is part of Hackensack Meridian Health’s Center for Discovery and Innovation, which has plans to open two additional centers, the Institute for Regenerative Medicine, and the Institute for Cancer and Infectious Diseases.

For more information about the Institute for Multiple Myeloma and the John Theurer Cancer Center, you can visit the website.

 

 

Hackensack Meridian Health. (2018, August 7). Hackensack Meridian Health Celebrates Opening of the Institute for Multiple Myeloma [Press Release] Retrieved from https://www.hackensackmeridianhealth.org/2018/08/07/hackensack-meridian-health-celebrates-opening-institute-multiple-myeloma/

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811